Alane P. Barnes

CIK: 0001584348

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (43.8%)

Position reduction

Option Exercises (M)3 (18.8%)

Derivative conversions

Awards (A)2 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BCRX

BIOCRYST PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

BCRX
BIOCRYST PHARMACEUTICALS INC
May 13, 2026
Exercise(M)
Direct
62.5K shares at avg. $5.04$315K
BCRX
BIOCRYST PHARMACEUTICALS INC
May 13, 2026
Sale(S)
Direct
62.5K shares at avg. $9.54$596K
BCRX
BIOCRYST PHARMACEUTICALS INC
Mar 16, 2026
Sale(S)
Direct
150K shares at avg. $9.15$1.4M
BCRX
BIOCRYST PHARMACEUTICALS INC
Mar 16, 2026
Exercise(M)
Direct
150K shares at avg. $5.51$827K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 22, 2025
Sale(S)
Direct
21.8K shares at avg. $7.65$167K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 19, 2025
Tax Payment(F)
Direct
16.9K shares at avg. $7.41$125K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 17, 2025
Award(A)
Direct
121.7K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 15, 2025
Sale(S)
Direct
21.2K shares at avg. $7.65$162K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 12, 2025
Tax Payment(F)
Direct
8.5K shares at avg. $7.57$65K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 3, 2025
Sale(S)
Direct
19.8K shares at avg. $7.65$151K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 2, 2025
Sale(S)
Direct
50.9K shares at avg. $7.21$367K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 1, 2025
Exercise(M)
Direct
91K shares at avg. $3.22$293K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 1, 2025
Sale(S)
Direct
91K shares at avg. $7.10$647K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 19, 2024
Award(A)
Direct
120.7K shares-
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 19, 2024
Tax Payment(F)
Direct
2.5K shares at avg. $7.39$18K
BCRX
BIOCRYST PHARMACEUTICALS INC
Dec 14, 2024
Tax Payment(F)
Direct
8.6K shares at avg. $7.53$65K

		Type	Shares	Price		Ownership
May 13, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	62,500	$5.04	$315,000	Direct
May 13, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	62,500	$9.54	$596,250	Direct
Mar 16, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	150,000	$9.15	$1,372,500	Direct
Mar 16, 2026	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	150,000	$5.51	$826,500	Direct
Dec 22, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	21,773	$7.65	$166,563	Direct
Dec 19, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	16,902	$7.41	$125,244	Direct
Dec 17, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	121,700	-	-	Direct
Dec 15, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	21,210	$7.65	$162,257	Direct
Dec 12, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	8,540	$7.57	$64,648	Direct
Dec 3, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	19,770	$7.65	$151,241	Direct
Dec 2, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	50,906	$7.21	$367,216	Direct
Dec 1, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Exercise(M)	91,004	$3.22	$293,033	Direct
Dec 1, 2025	BCRX BIOCRYST PHARMACEUTICALS INC	Sale(S)	91,004	$7.10	$646,511	Direct
Dec 19, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Award(A)	120,700	-	$0	Direct
Dec 19, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	2,461	$7.39	$18,187	Direct
Dec 14, 2024	BCRX BIOCRYST PHARMACEUTICALS INC	Tax Payment(F)	8,613	$7.53	$64,856	Direct

1-16 of 16 transactions

About Barnes Alane P

Barnes Alane P (SEC CIK 0001584348) files insider reports with the SEC as Chief Legal Officer of BIOCRYST PHARMACEUTICALS INC (BCRX).

Signal8 holds 8 ownership filings by Barnes Alane P, all Form 4s, filed between Dec 17, 2024 and May 15, 2026. Those filings report 16 transactions, from Dec 14, 2024 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Barnes Alane P's filings is in DURHAM, NC.

Recent filings by Barnes Alane P

May 13, 2026: Option exercise of BCRX shares (Form 4, code M).
May 13, 2026: Open-market sale of BCRX shares (Form 4, code S).
Mar 16, 2026: Open-market sale of BCRX shares (Form 4, code S).
Mar 16, 2026: Option exercise of BCRX shares (Form 4, code M).
Dec 22, 2025: Open-market sale of BCRX shares (Form 4, code S).

Other insiders filing for BIOCRYST PHARMACEUTICALS INC (BCRX)

Stonehouse Jon P, Director
Milne Jill C., Director
MILANO VINCENT, Director
McKee Amy E, Director
Frank Steven, Director
Galson Steven K, Director

How to read Form 4 transaction codes